News Migraine Startup Aims to Develop FDA-Approved Molecule into New Treatment Seurat Therapeutics has shared promising preclinical study results for its nasal spray designed to treat migraines by targeting several known causes of pain. “Migraine is such a large and fast-growing...
News A New Approach to Migraine Therapy University of Chicago researchers are opening a new front in treating migraine that could hold out hope for millions with the painful, debilitating condition—by mimicking the protective effects of physical...
News U of C Startup Seurat Therapeutics Announces $510K in Grant Funding Seurat Therapeutics, Inc. is a University of Chicago startup biotech company developing a nasal spray to treat and prevent migraines
News Nasal Spray for Migraines, Cooling Tower Water Treatment Receive $250 from UChicago Innovation Fund A nasal spray that can reduce migraine pain in 30 minutes, and a water treatment from Argonne National Laboratory that could save 4 million gallons of water from going to...
News Innovation Fund Invests $500,000 in Health and Energy Companies The University of Chicago Innovation Fund announced plans to invest up to $500,000 into two companies—Cephalgia Therapeutics and RWEDI water—that are working to combat migraines and increase water efficiency, respectively....
News A Company Focused on Ending the Misery of Chronic Migraines Modern life can be a headache. But there were evidently plenty of headaches back in the first century CE, when Aretaeus of Cappadocia, one of the most celebrated ancient Greek physicians,...
News Newest Members of the Polsky Incubator Selected The Polsky Center for Entrepreneurship and Innovation is pleased to announce the teams moving into the Polsky Incubator, which is located at the Polsky Center’s 34,000 square foot coworking space,...
News Microbiome Research Symposium Highlights Potential of Research-backed Startups to Impact Patient Care Scientists, faculty, entrepreneurs and researchers gathered at UChicago’s Microbiome Research Symposium on April 16 at the Logan Center for the Arts.
Page 2016-2017 I-Corps Teams Autumn 2016 Clarix Imaging Corporation: develops compact medical imaging devices and software for improving surgical oncology outcomes and reducing cost. ClostraBio,Inc.: a biopharma company developing therapeutics for food allergies. The company will...
News Polsky Center Announces Fall 2017 Incubator Cohort The Polsky Center for Entrepreneurship and Innovation has announced the companies that will be moving into the Polsky Incubator this October as members of the new cohort. The Polsky Incubator provides guidance,...
Technology Site-Directed RNA Editing Technology As A Novel Analgesic Use of RNA editing to modify NaV1.7 sodium channels in nociceptors, making them permeable to Na+ and K+ ions reducing the excitability of these pain-signaling neurons, providing a reversible, selective,…
